BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 926237)

  • 1. [Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].
    Ducros J; Benas P; Salvadori JM; Olmer M
    J Urol Nephrol (Paris); 1977 Sep; 83(9):735-8. PubMed ID: 926237
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.
    Strickland ID; Chaput de Saintonge DM; Boulton FE; Francis B; Roubikova J; Waters JI
    Clin Nephrol; 1977 Feb; 7(2):55-7. PubMed ID: 321170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous iron and chronic kidney disease.
    Auerbach M
    Am J Hematol; 2014 Nov; 89(11):1083. PubMed ID: 25219516
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum ferritin during hemodialysis. II: Outline for iron therapy].
    Marco Franco JE; Alarcón Zurita A; Morey Molina A; Pizá Buñola C; Bestard Palmer J; Mairata Bosch S; Galmés Llodra A; Dalmau Diana M
    Rev Clin Esp; 1982 Jan; 164(1):11-4. PubMed ID: 7071397
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow blood formation and iron stores in patients with chronic renal failure on maintenance hemodialysis.
    Shostka GD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):769-77. PubMed ID: 6176500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anemia in patients treated with periodic hemodialysis. Therapeutic criteria and long-term results].
    Bucciante G; Frizzi V; Bernardi AM; Amadori G
    Minerva Urol; 1978; 30(2):85-95. PubMed ID: 703731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with high-dose intravenous iron increases mortality and hospitalization in hemodialysis. The basic idea is more important than the style].
    Fernández-Gallego J
    Nefrologia; 2005; 25(3):340. PubMed ID: 16053019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of oral and parenteral iron therapy on the indicators of iron metabolism in patients with chronic hypochromic anemia].
    Mukhametdinova GM
    Probl Gematol Pereliv Krovi; 1973 Dec; 18(12):32-6. PubMed ID: 4789368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia in chronic hemodialysis].
    Helbig W; Achenbach H; Löbe J; Gottschild D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):242-57. PubMed ID: 69588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of anemia in hemodialysis, effect of intravenous iron without erythropoietin].
    Alvo M; Elgueta L; Aragón H; Cotera A
    Rev Med Chil; 2002 Aug; 130(8):865-8. PubMed ID: 12360794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.